Lopinavir/ritonavir/ribavirinVarious toxicities following off-label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1807卷 / 1期

关键词：

D O I：

10.1007/s40278-020-79399-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：113 / 113

相关论文

共 50 条

[1] Lopinavir/ritonavir/umifenovirNausea, vomiting and diarrhoea following off-label treatment: case report
Reactions Weekly, 2021, 1866 (1) : 240 - 240
[2] Lopinavir/ritonavir/sirolimus interactionHepatitis following an off-label use: case report
Reactions Weekly, 2022, 1908 (1) : 328 - 328
[3] Lopinavir/ritonavir/rocuronium bromide interactionMyopathy following off-label use: case report
Reactions Weekly, 2021, 1843 (1) : 231 - 231
[4] OsimertinibVarious toxicities following off-label treatment: case report
Reactions Weekly, 2018, 1724 (1) : 285 - 285
[5] GuselkumabVarious toxicities following off-label treatment: case report
Reactions Weekly, 2022, 1908 (1) : 264 - 264
[6] CannabidiolVarious toxicities following off-label treatment: case report
Reactions Weekly, 2021, 1860 (1) : 103 - 103
[7] Lopinavir/ritonavir/tocilizumabHypertriglyceridaemia following off-label use: 2 case reports
Reactions Weekly, 2020, 1824 (1) : 180 - 180
[8] Lopinavir/ritonavirHyperlipidaemia following off-label use: case report
Reactions Weekly, 2020, 1828 (1) : 303 - 303
[9] Lopinavir/ritonavirBradyarrhythmia following an off-label use : case report
Reactions Weekly, 2020, 1832 (1) : 186 - 186
[10] Immunosuppressants/rituximabVarious toxicities following an off-label treatment: case report
Reactions Weekly, 2022, 1924 (1) : 251 - 251

← 1 2 3 4 5 →